Deutsche Börse AG/BIOCOM AG

Latest investment trends were presented by BIOTECH Insight at the start of the German Equity Forum

AstraZeneca headquarters at Cambridge. 
© AstraZeneca  plc

C4X Discovery Holdings plc has exclusively licenced its NRF2 Activator programme to AstraZeneca and has got an upfront payment of $2m.

© PDPics/pixabay.com

Munich-based immunooncology specialist CatalYm GmbH wants to use €50m from a Series C financing round to advance its anti-GDF15 antibody to Phase II development.

Cultimate Foods' specialists are working on replicating animal fat tissue in the lab. ©Cultimate Foods UG

Cellular agriculture company Cultimate Foods UG has got a pre-seed funding led by Big Idea Ventures, ProVeg International and Realum.cloud.

Cradle BV Wet Lab. © Cradle

Biotech start-up Cradle BV has raised €5.4m in seed financing to design cell-factories with AI and scale bioprocesses much faster and cheaper.

© PublicDomainPictures/pixabay.com

Microbial casein maker Standing Ovation SA has inked an exklusive collaboration with Bel Group, one of France’s biggest cheese-makers to bring its vegan cheese to the market.

© Epiendo Pharmaceutical ehf

EpiEndo Pharmaceuticals ehf got the green light for a Phase IIa COPD trial with its non-anbibiotic macrolide EP395

© buffetcrush/pixabay.com

Danish Novo Nordisk Foundation has invested in Plant2Food, a new open innovation hub for researchers and companies to develop plant-based foods.

Founding team of Neotiv GmbH in 2018. © Guido Werner/GWP

German Neotiv GmbH hat closed a €10m seed financing to speed-up product launch of its early diagnosis app for Alzheimer’s disease

© gerald/pixabay.com

Jolt Capital contributed $20m to the BC Platforms’ data footprint expansion on November 8th.